Company financials

Agilent Technologies

Health Care Life Sciences Tools & Services Santa Clara, California Last filing Dec 22, 2025 · FY2025

                    Revenue
                    FY2025
                
$6.9B
                    3y CAGR +0.5%
                    
                    P17
                    
                    +6.7%
                    
                    Net income
                    FY2025
                
$1.3B
                    Net margin +18.8%
                    
                    P77
                    
                    +1.1%
                    
                    Total assets
                    FY2025
                
$12.7B
                    ROA +10.2%
                    
                    P72
                    
                    +7.4%
                    
                    Operating cash flow
                    FY2025
                
$1.6B
                    FCF margin +16.6%
                    
                    P55
                    
                    -11.0%

20 yrs · FY2006–FY2025 9 filed · 0 derived · 0 blank

1Y 3Y 5Y 10Y

Dollars % of revenue % of assets YoY % CAGR

Each cell as a share of that year’s total assets.

Balance Sheet

Assets, liabilities, and equity

31 accounts · 5 years

Total assets $12.7B

Total liabilities $6.0B

Shareholders equity $6.7B

Account	2025	2024	2023	2022	2021
Assets
Cash and Cash Equivalents	14.1%	11.2%	14.8%	10.0%	13.9%
Short Term Investments	0.0%	0.0%	0.0%	—	—
Accounts Receivable	11.7%	11.2%	12.0%	13.3%	10.9%
Inventory	8.1%	8.2%	9.6%	—	—
Prepaid Expenses	2.3%	2.8%	2.5%	—	—
Other Current Assets	2.3%	2.8%	2.5%	—	—
Total Current Assets	36.1%	33.4%	38.9%	35.9%	35.5%
Property,Plant and Equipment	15.9%	15.0%	11.8%	10.4%	8.8%
Operating Lease Assets	1.4%	1.5%	1.4%	1.4%	1.7%
Goodwill	35.1%	37.8%	36.8%	37.5%	37.1%
Intangible Assets	3.5%	4.6%	4.4%	—	—
Long Term Investments	1.0%	1.5%	1.5%	1.9%	1.7%
Other Noncurrent Assets	8.3%	7.7%	6.6%	6.5%	7.7%
Total Assets	100.0%	100.0%	100.0%	100.0%	100.0%
Liabilities
Accounts Payable	4.5%	4.6%	3.9%	5.5%	4.2%
Accrued Liabilities	3.5%	4.4%	4.1%	6.0%	6.2%
Deferred Revenue	4.9%	4.6%	4.7%	—	—
Current Portion of Long Term Debt	2.4%	0.4%	0.0%	—	—
Total Current Liabilities	18.4%	16.0%	14.9%	17.7%	16.0%
Long Term Debt	24.0%	28.2%	25.4%	25.9%	25.5%
Deferred Revenue Noncurrent	4.9%	4.6%	4.7%	—	—
Other Noncurrent Liabilities	3.6%	4.9%	4.4%	5.1%	6.2%
Total Liabilities	47.0%	50.2%	45.7%	49.6%	49.7%
Equity
Preferred Stock	0.0%	0.0%	0.0%	0.0%	0.0%
Common Stock	0.0%	0.0%	0.0%	0.0%	0.0%
Additional Paid In Capital	43.8%	46.0%	50.1%	50.6%	49.7%
Retained Earnings	10.9%	6.3%	7.3%	—	—
Treasury Stock	0.0%	0.0%	0.0%	—	—
Accumulated Other Comprehensive Income	-1.8%	-2.6%	-3.0%	—	—
Total Stockholders Equity	53.0%	49.8%	54.3%	50.4%	50.3%
Total Liabilitiesand Equity	100.0%	100.0%	100.0%	100.0%	100.0%

Income Statement

Revenue, expense, and profitability

20 accounts · 5 years

Revenue $6.9B

Operating income $1.5B

Net income $1.3B

Account	2025	2024	2023	2022	2021
IncomeStatement
Revenues Total Revenue	54.6%	55.0%	63.5%	—	—
Expenses Cost of Revenue	26.0%	25.1%	31.3%	—	—
Expenses Research and Development	3.6%	4.0%	4.5%	—	—
Expenses Selling,General and Administrative	13.4%	13.2%	15.2%	—	—
Expenses Depreciation and Amortization	2.3%	2.2%	2.5%	—	—
Expenses Share Based Compensation	1.0%	1.1%	1.0%	—	—
Expenses Restructuring and Asset Impairment	0.6%	0.6%	0.4%	—	—
Expenses Operating Expenses	43.0%	42.4%	50.9%	—	—
Other Income Expense Operating Income	11.6%	12.6%	12.5%	—	—
Other Income Expense Interest Income	0.5%	0.7%	0.5%	0.1%	0.0%
Other Income Expense Interest Expense	0.9%	0.8%	0.9%	0.8%	0.8%
Other Income Expense Other Income/expense	0.0%	0.4%	0.3%	—	—
Other Income Expense Income Before Tax	11.3%	12.8%	12.4%	—	—
Income Tax Income Tax Expense	1.0%	2.0%	0.9%	—	—
net Income net Income	10.2%	10.9%	11.5%	—	—
net Income Comprehensive Income	10.9%	11.1%	11.7%	—	—
Earnings Per Share Basic Eps	0.0%	0.0%	0.0%	—	—
Earnings Per Share Diluted Eps	0.0%	0.0%	0.0%	—	—
Earnings Per Share Weighted Average Shares Basic	2.2%	2.4%	2.7%	—	—
Earnings Per Share Weighted Average Shares Diluted	2.2%	2.5%	2.8%	—	—

Cash Flow Statement

Operating, investing, and financing flows

22 accounts · 5 years

Operating cash flow $1.6B

Investing cash flow $-394.0M

Financing cash flow $-715.0M

Account	2025	2024	2023	2022	2021
CashFlow
Operating Activities net Income	10.2%	10.9%	11.5%	—	—
Operating Activities Depreciation and Amortization	2.3%	2.2%	2.5%	3.0%	3.0%
Operating Activities Stock Based Compensation	1.0%	1.1%	1.0%	—	—
Operating Activities Deferred Income Taxes	-1.0%	-0.5%	-0.5%	0.1%	0.1%
Operating Activities Changes In Operating Assets and Liabilities	6.5%	4.4%	1.8%	0.1%	0.1%
Operating Activities net Cash From Operating Activities	12.2%	14.8%	16.5%	12.5%	13.9%
Investing Activities Capital Expenditures	3.2%	3.2%	2.8%	—	—
Investing Activities Business Acquisitions	-0.0%	7.3%	0.5%	—	—
Investing Activities Purchases of Investments	0.0%	0.0%	0.1%	—	—
Investing Activities net Cash From Investing Activities	-3.1%	-10.6%	-2.9%	-3.2%	-7.0%
Financing Activities Proceeds From Debt	0.0%	10.1%	0.0%	—	—
Financing Activities Repayment of Debt	0.0%	5.1%	0.0%	—	—
Financing Activities Repurchase of Common Stock	3.3%	9.7%	5.3%	—	—
Financing Activities Dividends Paid	2.2%	2.3%	2.5%	—	—
Financing Activities Proceeds From Stock Issuance	0.6%	0.7%	0.6%	—	—
Financing Activities Tax Withholding On Stock Based Compensation	0.2%	0.3%	0.5%	—	—
Financing Activities Other Financing Activities	0.0%	0.0%	0.0%	—	—
Financing Activities net Cash From Financing Activities	-5.6%	-6.3%	-8.6%	-13.0%	-6.5%
Cash Reconciliation Effect of Exchange Rate On Cash	0.1%	-0.0%	0.0%	—	—
Cash Reconciliation net Change In Cash	3.6%	-2.2%	5.0%	—	—
Cash Reconciliation Cash At Beginning of Period	14.1%	11.2%	14.8%	—	—
Cash Reconciliation Cash At End of Period	14.1%	11.2%	14.8%	—	—

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 5 years

Ratio	2025	2024	2023	2022	2021
Profitability
Gross margin	+52.4%	+54.3%	+50.7%	+54.4%	+53.9%
Operating margin	+21.3%	+22.9%	+19.8%	+23.6%	+21.3%
Net margin	+18.8%	+19.8%	+18.1%	—	+19.1%
FCF margin	+16.6%	+21.1%	+21.6%	+14.9%	+20.5%
Growth
Revenue CAGR (3y)	+0.5%	+1.0%	+8.6%	+9.9%	+8.7%
Returns
ROE	+19.3%	+21.9%	+21.2%	—	+22.5%
ROA	+10.2%	+10.9%	+11.5%	—	+11.3%
ROIC	+16.2%	+15.8%	+17.9%	+23.0%	+20.3%
Liquidity
Current ratio	1.96x	2.09x	2.61x	2.03x	2.22x
Quick ratio	1.40x	1.40x	1.80x	1.32x	1.56x
Leverage
D/E	0.89x	1.01x	0.84x	0.99x	0.99x
Interest coverage	13.21x	15.50x	14.21x	19.26x	16.63x
Efficiency
Asset turnover	0.55x	0.55x	0.63x	0.65x	0.59x
Cash conversion cycle	+128d	+127d	+135d	+128d	+116d

Valuation

Price against fundamentals

A $115 · 2026-04-02 · 166d old · FY2025

Market cap $32.9B

P/E 25.26x

P/S 4.74x

P/B 4.88x

EV $34.5B

EV/EBITDA 19.51x

FCF yield +3.5%

Dividend yield +0.9%

Notes

Your annotations

Not watched